Novo Integrated Sciences Stock Current Valuation
| NVOSDelisted Stock | USD 0.04 0.01 17.57% |
Valuation analysis of Novo Integrated Sciences helps investors to measure Novo Integrated's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Novo Integrated's price fluctuation is out of control at this time. Calculation of the real value of Novo Integrated Sciences is based on 3 months time horizon. Increasing Novo Integrated's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Novo otc stock is determined by what a typical buyer is willing to pay for full or partial control of Novo Integrated Sciences. Since Novo Integrated is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Novo OTC Stock. However, Novo Integrated's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0441 | Real 0.0419 | Hype 0.04 |
The intrinsic value of Novo Integrated's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Novo Integrated's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Novo Integrated Sciences helps investors to forecast how Novo otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Novo Integrated more accurately as focusing exclusively on Novo Integrated's fundamentals will not take into account other important factors: Novo Integrated Sciences OTC Stock Current Valuation Analysis
Novo Integrated's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Novo Integrated Current Valuation | 5.8 M |
Most of Novo Integrated's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Novo Integrated Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Novo Integrated Sciences has a Current Valuation of 5.8 M. This is 99.96% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.97% higher than that of the company.
Novo Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novo Integrated's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Novo Integrated could also be used in its relative valuation, which is a method of valuing Novo Integrated by comparing valuation metrics of similar companies.Novo Integrated is currently under evaluation in current valuation category among its peers.
Novo Fundamentals
| Return On Equity | -1.35 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | (1.80) % | ||||
| Operating Margin | (0.80) % | ||||
| Current Valuation | 5.8 M | ||||
| Shares Outstanding | 19.05 M | ||||
| Shares Owned By Insiders | 6.82 % | ||||
| Shares Owned By Institutions | 5.77 % | ||||
| Number Of Shares Shorted | 274.86 K | ||||
| Price To Book | 0.29 X | ||||
| Price To Sales | 0.21 X | ||||
| Revenue | 12.57 M | ||||
| Gross Profit | 3.82 M | ||||
| EBITDA | (5.63 M) | ||||
| Net Income | (13.27 M) | ||||
| Cash And Equivalents | 12.68 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 4.47 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.52 X | ||||
| Cash Flow From Operations | (2.24 M) | ||||
| Short Ratio | 1.13 X | ||||
| Earnings Per Share | (0.41) X | ||||
| Number Of Employees | 127 | ||||
| Beta | -0.69 | ||||
| Market Capitalization | 2.84 M | ||||
| Total Asset | 35.56 M | ||||
| Retained Earnings | (67.03 M) | ||||
| Working Capital | (3.52 M) | ||||
| Net Asset | 35.56 M |
About Novo Integrated Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novo Integrated Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novo Integrated using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novo Integrated Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Integrated Sciences. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Novo OTC Stock
If you are still planning to invest in Novo Integrated Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novo Integrated's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |